Buscar
Mostrando ítems 1-10 de 12
Função sistólica do ventrículo esquerdo pela ecocardiografia em crianças e adolescentes com osteossarcoma tratados com doxorrubicina com e sem dexrazoxane
(Sociedade Brasileira de Cardiologia - SBC, 2006-12-01)
OBJECTIVE: To evaluate left ventricular (LV) systolic function by means of echocardiography in patients with osteosarcoma treated with doxorubicin alone or in combination with dexrazoxane. METHODS: The study analyzed 55 ...
Terapêutica citoprotetora em pacientes tratados com quimio e/ou radioterapia anti neoplásicaCytoprotective therapy in patients treated with chemotherapy and/or antineoplasic radiotherapy
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2000)
Measuring the impact of dexrazoxane cardioprotection - Response
(Wiley-Blackwell, 2007-04-01)
Eficácia do dexrazoxano na prevenção de cardiotoxicidade em pacientes com câncer de mama expostos à quimioterapia com antraciclina, associado ou não ao trastuzumabe: revisão sistemática e metanálise
(Universidade Federal de Minas GeraisBrasilMEDICINA - FACULDADE DE MEDICINAPrograma de Pós-Graduação em Ciências Aplicadas à Saúde do AdultoUFMG, 2018-05-28)
Background: Anthracyclines continue to rank among the most effective agents in
breast cancer (BC) treatment, but its use is limited by a dose-dependent cardiotoxicity.
Clinical studies have suggested that dexrazoxane ...
Tratamento de complicações associadas ao extravasamento de drogas antineoplásicas: revisão integrativa da literatura
(Universidade Federal de Minas GeraisBrasilENFERMAGEM - ESCOLA DE ENFERMAGEMCurso de Especialização em EnfermagemUFMG, 2012-08-31)
The cancer that is considered a chronic degenerative disease in recent decades,
gained a larger, becoming an obvious public health problem worldwide. The
anticancer treatment called chemotherapy have more advanced every ...
Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers
(Adis Int Ltd, 2014-10-01)
In the US, children diagnosed with cancer are living longer, but not without consequences from the same drugs that cured their cancer. in these patients, cardiovascular disease is the leading cause of non-cancer-related ...